Scientists Behind Orexin Discovery Honored with Lasker Prize
The Lasker Award, a top medical research honor, has been bestowed on the team that identified orexin, a neuropeptide essential for regulating sleep and wakefulness. Their foundational work has paved the way for new treatments for sleep disorders such as narcolepsy. The announcement appeared in a biotech news roundup that also mentioned a new FDA CBER head and a startup from AI company Schrodinger.
The Lasker Prize, a prestigious medical accolade, now honors the researchers who discovered the neuropeptide orexin. This molecule plays a central role in governing the body's sleep-wake cycle, acting as a crucial biological signal.
Their foundational work has laid the groundwork for innovative therapies targeting sleep disorders, including narcolepsy. The award was highlighted within a recent industry digest that also covered other regulatory and corporate developments.
This recognition could spur further investment into sleep-related drug development. Patients with narcolepsy and other circadian disruptions may eventually benefit from more precise treatments targeting orexin pathways. The award also underscores how fundamental biological discoveries can translate into practical therapies, potentially improving daily functioning and safety for millions affected by chronic sleep issues.